Neuroinflammatory process involved in different preclinical models of chemotherapy-induced peripheral neuropathy

G Fumagalli, L Monza, G Cavaletti, R Rigolio… - Frontiers in …, 2021 - frontiersin.org
Peripheral neuropathies are characterized by nerves damage and axonal loss, and they
could be classified in hereditary or acquired forms. Acquired peripheral neuropathies are …

Cisplatin mouse models: treatment, toxicity and translatability

M Perše - Biomedicines, 2021 - mdpi.com
Cisplatin is one of the most widely used chemotherapeutic drugs in the treatment of a wide
range of pediatric and adult malignances. However, it has various side effects which limit its …

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials

TA Yap, N Daver, M Mahendra, J Zhang… - Nature medicine, 2023 - nature.com
Although targeting oxidative phosphorylation (OXPHOS) is a rational anticancer strategy,
clinical benefit with OXPHOS inhibitors has yet to be achieved. Here we advanced IACS …

Quantitative differences in neuronal subpopulations between mouse and human dorsal root ganglia demonstrated with RNAscope in situ hybridization

S Shiers, RM Klein, TJ Price - Pain, 2020 - journals.lww.com
Next-generation transcriptomics in combination with imaging-based approaches have
emerged as powerful tools for the characterization of dorsal root ganglion (DRG) neuronal …

Chemotherapy-induced peripheral neuropathy: part 1—current state of knowledge and perspectives for pharmacotherapy

K Sałat - Pharmacological reports, 2020 - Springer
Background Despite the increasing knowledge of the etiology of neuropathic pain, this type
of chronic pain is resistant to available analgesics in approximately 50% of patients and …

Mini-Review: Mitochondrial dysfunction and chemotherapy-induced neuropathic pain

TM Doyle, D Salvemini - Neuroscience letters, 2021 - Elsevier
Chemotherapy-induced peripheral neuropathy (CIPN) is a somatosensory axonopathy in
cancer patients receiving any of a variety of widely-use antitumor agents. CIPN can lead to …

A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)

S Shen, AP Kozikowski - Expert opinion on therapeutic patents, 2020 - Taylor & Francis
ABSTRACT Introduction: Histone deacetylase 6 (HDAC6) is unique in comparison with other
zinc-dependent HDAC family members. An increasing amount of evidence from clinical and …

Targeting the A3 adenosine receptor to prevent and reverse chemotherapy-induced neurotoxicities in mice

AK Singh, R Mahalingam, S Squillace… - Acta Neuropathologica …, 2022 - Springer
Cisplatin is used to combat solid tumors. However, patients treated with cisplatin often
develop cognitive impairments, sensorimotor deficits, and peripheral neuropathy. There is …

Axon guidance molecules and pain

E Damo, M Simonetti - Cells, 2022 - mdpi.com
Chronic pain is a debilitating condition that influences the social, economic, and
psychological aspects of patients' lives. Hence, the need for better treatment is drawing …

HDAC6: a key link between mitochondria and development of peripheral neuropathy

K English, MC Barton - Frontiers in Molecular Neuroscience, 2021 - frontiersin.org
Peripheral neuropathy, which is the result of nerve damage from lesions or disease,
continues to be a major health concern due to the common manifestation of neuropathic …